<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An asymptomatic 67-year-old man presented with a left supraclavicular lymph node that enlarged over a 2-month period which was biopsied </plain></SENT>
<SENT sid="1" pm="."><plain>Pathologic features were consistent with involvement by metastatic <z:mpath ids='MPATH_317'>seminoma</z:mpath> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular pattern, grade 1 (of 3) </plain></SENT>
<SENT sid="2" pm="."><plain>Staging <z:chebi fb="4" ids="30225">Positron</z:chebi> Emission Tomography/Computed Tomography scans indicated several areas of <z:mp ids='MP_0000702'>enlarged lymph nodes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient completed chemotherapy with <z:chebi fb="0" ids="3139">bleomycin</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi>, and <z:chebi fb="2" ids="27899">cisplatin</z:chebi> chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>This is the first reported case of metastatic <z:mpath ids='MPATH_317'>seminoma</z:mpath> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurring in the same lymph node </plain></SENT>
<SENT sid="5" pm="."><plain>No obvious pathophysiologic link exists between these two <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and there are no shared common risk factors </plain></SENT>
<SENT sid="6" pm="."><plain>Given the natural history of these two <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, if this patient develops recurrent <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, it will be difficult to identify whether the <z:mp ids='MP_0000702'>enlarged lymph nodes</z:mp> represent recurrent <z:mpath ids='MPATH_317'>seminoma</z:mpath> or follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> without a biopsy of each pathologically enlarged node </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, Fluorodeoxyglucose- <z:chebi fb="4" ids="30225">Positron</z:chebi> Emission Tomography is known to be active in both <z:mpath ids='MPATH_317'>seminoma</z:mpath> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, making this scan non-specific in this patient </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, this patient had no baseline elevation in any <z:mpath ids='MPATH_310'>germ cell tumor</z:mpath> marker </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, serum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers cannot be relied upon as surrogates for response to chemotherapy or as identifiers of relapsed <z:mpath ids='MPATH_317'>seminoma</z:mpath> </plain></SENT>
</text></document>